Apicomplexa

  • Effects of PERK eIF2α Kinase Inhibitor against <span class="named-content genus-species" id="named-content-1">Toxoplasma gondii</span>
    Experimental Therapeutics
    Effects of PERK eIF2α Kinase Inhibitor against Toxoplasma gondii

    Toxoplasma gondii is an obligate intracellular parasite that has infected one-third of the population. Upon infection of warm-blooded vertebrates, the replicating form of the parasite (tachyzoite) converts into a latent form (bradyzoite) present in tissue cysts.

    Leonardo Augusto, Jennifer Martynowicz, Kirk A. Staschke, Ronald C. Wek, William J. Sullivan
Back to top